Steve W. Elmore

538 total citations
4 papers, 437 citations indexed

About

Steve W. Elmore is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Steve W. Elmore has authored 4 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Hematology. Recurrent topics in Steve W. Elmore's work include Cell death mechanisms and regulation (4 papers), Cancer therapeutics and mechanisms (2 papers) and Lung Cancer Research Studies (2 papers). Steve W. Elmore is often cited by papers focused on Cell death mechanisms and regulation (4 papers), Cancer therapeutics and mechanisms (2 papers) and Lung Cancer Research Studies (2 papers). Steve W. Elmore collaborates with scholars based in United States and United Kingdom. Steve W. Elmore's co-authors include Mark G. Anderson, Stephen K. Tahir, Christin Tse, Saul H. Rosenberg, Susan E. Morgan-Lappe, Robert B. Warner, Jun Chen, Aparna V. Sarthy, Shi‐Chung Ng and Stephen W. Fesik and has published in prestigious journals such as Blood, Cancer Research and Oncogene.

In The Last Decade

Steve W. Elmore

4 papers receiving 428 citations

Peers

Steve W. Elmore

MB

ONCOL

CR

IMMUN

PFM

Aaron M. Domina United States

Hélène Malka-Mahieu France

Michael Grondine United States

Elizabeth Moskatel United States

Steven DellaRocca United States

Silvia Escudero United States

Elizabeth Blackwood United States

Tapan Bagui United States

Janice M. Mehnert United States

Liv Johannessen United States

Aaron M. Domina United States

Steve W. Elmore

353 ×1.0

MB

143 ×0.8

ONCOL

51 ×1.1

CR

64 ×1.4

IMMUN

45 ×1.1

PFM

Citations per year, relative to Steve W. Elmore Steve W. Elmore (= 1×) peers Aaron M. Domina

Countries citing papers authored by Steve W. Elmore

Since Specialization

Citations

This map shows the geographic impact of Steve W. Elmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve W. Elmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve W. Elmore more than expected).

Fields of papers citing papers by Steve W. Elmore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve W. Elmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve W. Elmore. The network helps show where Steve W. Elmore may publish in the future.

Co-authorship network of co-authors of Steve W. Elmore

This figure shows the co-authorship network connecting the top 25 collaborators of Steve W. Elmore. A scholar is included among the top collaborators of Steve W. Elmore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve W. Elmore. Steve W. Elmore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Sampath, Deepak, Elizabeth A. Punnoose, Erwin R. Boghaert, et al.. (2012). Expression of Bcl-2 Pro-Survival Family Proteins Predicts Pharmacological Responses to ABT-199, a Novel and Selective Bcl-2 Antagonist, in Multiple Myeloma Models. Blood. 120(21). 5028–5028. 2 indexed citations

2.

Tahir, Stephen K., John Wass, Mary K. Joseph, et al.. (2010). Identification of Expression Signatures Predictive of Sensitivity to the Bcl-2 Family Member Inhibitor ABT-263 in Small Cell Lung Carcinoma and Leukemia/Lymphoma Cell Lines. Molecular Cancer Therapeutics. 9(3). 545–557. 59 indexed citations

3.

Roberts, Lisa, et al.. (2010). Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines. Oncogene. 30(16). 1963–1968. 126 indexed citations

4.

Tahir, Stephen K., Xiufen Yang, Mark G. Anderson, et al.. (2007). Influence of Bcl-2 Family Members on the Cellular Response of Small-Cell Lung Cancer Cell Lines to ABT-737. Cancer Research. 67(3). 1176–1183. 250 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact